Ditchcarbon
  • Contact
  1. Organizations
  2. Rugby Laboratories, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

Rugby Laboratories, Inc. Sustainability Profile

Company website

Rugby Laboratories, Inc., a prominent player in the pharmaceutical and biotechnology industry, is headquartered in the United States. Founded in 1992, the company has established itself as a leader in providing high-quality laboratory services, specialising in analytical testing and product development for the pharmaceutical sector. With a strong presence across North America and Europe, Rugby Laboratories is renowned for its commitment to innovation and regulatory compliance. The company offers a diverse range of core services, including stability testing, microbiological testing, and method development, all tailored to meet the stringent requirements of its clients. Rugby Laboratories distinguishes itself through its state-of-the-art facilities and a team of experienced professionals dedicated to delivering precise and reliable results. Recognised for its exceptional quality and customer service, Rugby Laboratories continues to solidify its market position as a trusted partner in the pharmaceutical landscape.

DitchCarbon Score

How does Rugby Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

70

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Rugby Laboratories, Inc.'s score of 70 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

83%

Let us know if this data was useful to you

Rugby Laboratories, Inc.'s reported carbon emissions

Inherited from Cardinal Health, Inc.

Rugby Laboratories, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Cardinal Health, Inc., and therefore, any climate commitments or emissions data may be inherited from its parent organisation. As a part of its corporate family, Rugby Laboratories aligns with the sustainability initiatives and targets set by Cardinal Health, Inc. This includes participation in various climate-related frameworks, such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Cardinal Health at a third-level relationship. However, specific reduction targets or achievements for Rugby Laboratories are not detailed in the available information. While Rugby Laboratories has not disclosed its own emissions or reduction initiatives, it is essential to note that the company is part of a broader commitment to sustainability and climate action through its affiliation with Cardinal Health. This relationship may provide a pathway for future emissions reporting and climate commitments as the industry increasingly prioritises environmental responsibility.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2009201020162017201820192021202220232024
Scope 1
148,856,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
212,644,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
00,000,000
-
-
-
00,000,000,000
00,000,000,000

How Carbon Intensive is Rugby Laboratories, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Rugby Laboratories, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Rugby Laboratories, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Rugby Laboratories, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Rugby Laboratories, Inc.'s Scope 3 Categories Breakdown

Rugby Laboratories, Inc.'s Scope 3 emissions, which increased by 5% last year and increased significantly since 2018, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 93% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
93%
Upstream Transportation & Distribution
6%
Fuel and Energy Related Activities
<1%
End-of-Life Treatment of Sold Products
<1%
Capital Goods
<1%
Use of Sold Products
<1%
Employee Commuting
<1%
Investments
<1%
Waste Generated in Operations
<1%
Business Travel
<1%

Rugby Laboratories, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Rugby Laboratories, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Rugby Laboratories, Inc.'s Emissions with Industry Peers

Bristol-Myers Squibb de Mexico S. de R. L. de C.V.

MX
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Prestige Brands, Inc.

US
•
Machinery and equipment n.e.c. (29)
Updated 24 days ago

McNeil Consumer Pharmaceuticals Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Novartis Consumer Health, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251120.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy